menu
    • menu

    Company profile for Galderma

    NEW Drugs in Dev: 35
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Galderma, the world's largest independent global dermatology company, was created in 1981 and is now present in over 100 countries with an extensive product portfolio of prescription medicines, aesthetics solutions and consumer care products. The company partners with health care practitioners around the world to meet the skin health needs of people throughout their lifetime. Galderma is a leader in research and development of...
    Galderma, the world's largest independent global dermatology company, was created in 1981 and is now present in over 100 countries with an extensive product portfolio of prescription medicines, aesthetics solutions and consumer care products. The company partners with health care practitioners around the world to meet the skin health needs of people throughout their lifetime. Galderma is a leader in research and development of scientifically-defined and medically-proven solutions for the skin.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    GaldermaSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    World Trade Center, Avenue Gratta-Paille 2, 1018 Lausanne
    Telephone
    Telephone
    +41 21 642 78 00
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.galderma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/galderma-/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/galderma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Nemolizumab Shows Benefit In Pediatric AD At AAD 2026
    Nemolizumab Shows Benefit In Pediatric AD At AAD 2026

    28 Mar 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260328320362/en/AAD-2026-Late-Breaking-Nemolizumab-Data-Demonstrate-Clinically-Meaningful-Benefits-for-Children-Aged-2-to-11-With-Moderate-to-Severe-Atopic-Dermatitis

    BUSINESSWIRE
    28 Mar 2026
    Share Share
    Galderma Highlights Skin Solutions Data At AAD 2026
    Galderma Highlights Skin Solutions Data At AAD 2026

    24 Mar 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260323553707/en/AAD-2026-Galderma-Showcases-Latest-Evidence-Supporting-Its-Full-Spectrum-Science-Driven-Solutions-for-Diverse-Skin-Needs

    BUSINESSWIRE
    24 Mar 2026
    Share Share
    Galderma Receives U.S. FDA Approval for Restylane Contour
    Galderma Receives U.S. FDA Approval for Restylane Contour

    23 Mar 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260322108467/en/Galderma-Receives-U.S.-FDA-Approval-for-Restylane-Contour-for-the-Correction-of-Temple-Hollowing

    BUSINESSWIRE
    23 Mar 2026
    Share Share
    Galderma Releases 2026 AGM Invitation and Agenda
    Galderma Releases 2026 AGM Invitation and Agenda

    20 Mar 2026

    // BUSSINESSWIRE

    https://www.businesswire.com/news/home/20260319216368/en/Galderma-Publishes-Invitation-and-Agenda-for-Its-2026-Annual-General-Meeting

    BUSSINESSWIRE
    20 Mar 2026
    Share Share
    Galderma Showcases Aesthetic Innovation At AMWC 2026
    Galderma Showcases Aesthetic Innovation At AMWC 2026

    17 Mar 2026

    // BUSSINESSWIRE

    https://www.businesswire.com/news/home/20260316497387/en/AMWC-2026-Galderma-Showcases-Categoryleading-Innovation-With-a-Comprehensive-Portfolio-and-Holistic-Futurefocused-Aesthetic-Strategies

    BUSSINESSWIRE
    17 Mar 2026
    Share Share
    Galderma Buys Back Shares Worth CHF 232 Million
    Galderma Buys Back Shares Worth CHF 232 Million

    11 Mar 2026

    // BUSSINESSWIRE

    https://www.businesswire.com/news/home/20260310572494/en/Galderma-Buys-Back-Shares-Worth-CHF-232-Million-in-the-Context-of-Accelerated-Bookbuild-Offering

    BUSSINESSWIRE
    11 Mar 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search